Decline in acute urinary toxicity: A long-term study in 2011 patients with prostate brachytherapy within a provincial institution

Acute AUR and RTOG urinary toxicity rates continue to decline with the increasing experience of our provincial prostate brachytherapy program, despite its expansion to new centers and addition of members. This is likely due to better patient selection, refinement in treatment planning and implantation technique, and mentorship and training process.